Metabolic Diseases


Symptoms


Metabolic defect


Clinical manifestations


Myopathy, stress intolerance


Mitochondrial disorder


Electron transport chain defects


 


Lysosomal disorder


Glycogen storage disease type II, Danon’s disease


 


Defect in purine metabolism


Myoadenylate deaminase deficiency


Neuropathy


Lysosomal disorder


Fabry’s disease, Krabbe’s disease, metachromatic leukodystrophy


 


Peroxisomal disorder


Refsum’s disease, adrenoleukodystrophy/adrenomyeloneuropathy


 


Mitochondrial disorder


Electron transport chain defects


 


Defect in cholesterol metabolism


Cerebrotendinous xanthomatosis


 


Defect in heme biosynthesis


Porphyria


Spinal muscular atrophy


Lysosomal disorder


GM2 gangliosidosis


Spasticity


Mitochondrial disorder


Electron transport chain defects


 


Lysosomal disorder


GM1 gangliosidosis, GM2 gangliosidosis, Gaucher’s disease type 3, Krabbe’s disease, metachromatic leukodystrophy, Salla disease


 


Peroxisomal disorder


Refsum’s disease, adrenoleukodystrophy/adrenomyeloneuropathy


 


Defect in cholesterol metabolism


Cerebrotendinous xanthomatosis


 


Defect in urea cycle


Arginase deficiency


Progressive ataxia


Mitochondrial disorder


Pyruvate dehydrogenase deficiency, electron transport chain defects


 


Lysosomal disorder


GM2 gangliosidosis, metachromatic leukodystrophy, Niemann-Pick disease type C, sialidosis, Salla disease


 


Peroxisomal disorder


Refsum’s disease, adrenoleukodystrophy/adrenomyeloneuropathy


 


Defect in cholesterol metabolism


Cerebrotendinous xanthomatosis


 


Defect in copper metabolism


Wilson’s disease


 


Defect in lipid metabolism


Abetalipoproteinemia


Extrapyramidal symptoms


Mitochondrial disorder


Electron transport chain defects


 


Lysosomal disorder


GM1 gangliosidosis, GM2 gangliosidosis (Tay-Sachs disease, Sandhoff’s disease), metachromatic leukodystrophy, Niemann–Pick disease type C, neuronal ceroid lipofuscinosis (Spielmeyer–Vogt disease, Kufs’ disease)


 


Peroxisomal disorder


Adrenoleukodystrophy


 


Defect in cholesterol metabolism


Cerebrotendinous xanthomatosis


 


Defect in copper metabolism


Wilson’s disease


 


Defect in purine metabolism


Lesch-Nyhan syndrome


 


Organic acid disorder


Glutaric aciduria type I


Leukodystrophy/leukoencephalopathy (specific patterns of distribution)


Mitochondrial disorder


Lysosomal disorder


Peroxisomal disorder


Defect in cholesterol metabolism


Organic acid disorder


Electron transport chain defects


Krabbe’s disease, metachromatic leukodystrophy


Adrenoleukodystrophy


Cerebrotendinous xanthomatosis


Canavan’s disease


(Myoclonic) epilepsy


Mitochondrial disorder


Lysosomal disorder


Pyruvate dehydrogenase deficiency, electron transport chain defects


Sialidosis, neuronal ceroid lipofuscinosis (Spielmeyer-Vogt disease, Kufs’ disease)


Behavioral abnormalities, psychosis, dementia


Mitochondrial disorder


Lysosomal disorder


Electron transport chain defects


Fabry’s disease, GM2 gangliosidosis (Tay–Sachs disease, Sandhoff’s disease), Gaucher’s disease type 3, metachromatic leukodystrophy, Niemann-Pick disease type C, neuronal ceroid lipofuscinosis (Spielmeyer-Vogt disease, Kufs’ disease)


 


Peroxisomal disorder


Adrenoleukodystrophy


 


Defect in cholesterol metabolism


Cerebrotendinous xanthomatosis


 


Defect in copper metabolism


Wilson’s disease


 


Defect in amino acid metabolism


Homocystinuria


 


Defect in urea cycle


Ornithine transcarbamylase deficiency


Loss of vision


Mitochondrial disorder


Electron transport chain defects


 


Lysosomal disorder


Neuronal ceroid lipofuscinosis (Spielmeyer-Vogt disease), sialidosis


 


Peroxisomal disorder


Refsum’s disease


 


Defect in urea cycle


Ornithine aminotransferase deficiency


Ophthalmoplegia


Mitochondrial disorder


Electron transport chain defects


 


Lysosomal disorder


Gaucher’s disease type 3, Niemann-Pick disease type C


Stroke, stroke-like episodes


Mitochondrial disorder


Electron transport chain defects


 


Lysosomal disorder


Fabry’s disease


 


Defect in amino acid metabolism


Homocystinuria, methylene tetrahydrofolate reductase deficiency


 


Defect in urea cycle


Ornithine transcarbamylase deficiency


Recurrent attacks of ataxia


Mitochondrial disorder


Pyruvate dehydrogenase deficiency, electron transport chain defects


 


Defect in amino acid metabolism


Branched-chain organic aciduria, methylene tetrahydrofolate reductase deficiency


 


Defect in urea cycle


Ornithine transcarbamylase deficiency


Recurrent psychiatric symptoms


Defect in amino acid metabolism


Methylene tetrahydrofolate reductase deficiency


 


Organic acid disorder


Branched-chain organic acid disorder


 


Defect in urea cycle


Ornithine transcarbamylase deficiency


 


Defect in heme biosynthesis


Acute porphyria


Mitochondrial Diseases



Definition of Mitochondrial Diseases


The term “mitochondrial diseases” does not apply to all disorders of metabolism in mitochondria: it refers only to impairments of the energy metabolism, particularly those of the electron transport chain (respiratory chain), and in part also to disturbances of the immediate pyruvate metabolism and the citrate cycle.


Epidemiology

The estimated prevalence of mitochondrial diseases is 15 per 100 000 head of population.


Physiology and Etiology

Mitochondria are cellular organelles surrounded by a double membrane; inside these organelles, diverse metabolic processes take place (Fig. 17.1):


• Dehydrogenation and decarboxylation of pyruvate to acetyl CoA.


• The subsequent citrate cycle.


• Oxidative phosphorylation in the electron transport chain.


• β-Oxidation of fatty acids.


• Parts of the urea cycle.


The electron transport chain, in which the reoxidation of coenzymes is coupled to the synthesis of adenosine triphosphate (ATP)—the central energy source of the cell—consists of five enzyme complexes:


• Complex I: ubiquinone reductase.


• Complex II: succinate dehydrogenase.


• Complex III: cytochrome c oxidoreductase.


• Complex IV: cytochrome c oxidase (COX).


• Complex V: ATP synthase.


Mitochondria are inherited maternally and contain several copies of their own mitochondrial DNA (mtDNA). The mitochondrial DNA consists of a circular double strand of 16 569 base pairs; it codes for 13 polypeptides of the electron transport chain (mit genes) and also for two ribosomal RNAs and 22 transfer RNAs (syn genes). The majority of mitochondrial proteins, however, are encoded by nuclear DNA (nDNA) and are imported into the mitochondria after synthesis. Gene products of nDNA are also essential for maintaining and replicating the mtDNA. Normally, an organism contains only one mtDNA species. When a mutation occurs, a cell often contains both mutant mtDNA and wildtype mtDNA (heteroplasmy), with both being randomly distributed during cell division. As a result, one cell may receive only mutant DNA and another only wild-type DNA (segregation). Cell functions are only affected when the proportion of mutant mtDNA within a cell exceeds a critical threshold level. This explains, in part, the different manifestations of mtDNA mutations within a family.


image


Fig. 17.1 Mitochondrial metabolism.


PDH, pyruvate dehydrogenase Electron transport chain (respiratory chain):




























Complex I


—ubiquinone reductase


Complex II


—succinate CO oxidoreductase


Complex III


—cytochrome c oxidoreductase


Complex IV


—cytochrome c oxidase (COX)


Complex V


—ATP synthase


CoQ


—coenzyme Q


Cyt c


—cytochrome c


 















































Table 17.2 Symptoms of electron transport chain defects

Organ


Symptoms


Central nervous system


Epilepsy, stroke-like episodes, lethargy, coma, psychosis, retardation, spasticity, dystonia, ataxia, paraparesis, myoclonus, cranial nerve defects, strabismus, nystagmus, central hypotension, cortical blindness, sensorineural loss of hearing


Peripheral nervous system


Sensorimotor axonal neuropathy


Muscles


Hypotension, weakness, stress intolerance, ptosis


Eyes


Retinitis pigmentosa, optic atrophy, cataract


Heart


Cardiomyopathy (usually hypertrophic), arrhythmia, impaired conduction


Liver


Liver failure (especially in infancy)


Pancreas


Exocrine pancreatic insufficiency


Gastrointestinal tract


Vomiting, diarrhea, villous atrophy, intestinal pseudo-obstruction


Kidney


Proximal tubulopathy with aminoaciduria, focal segmental glomerulosclerosis


Endocrine system


Diabetes mellitus, diabetes insipidus, short stature, hypothalamic hypogonadism, hypothyroidism, hypoparathyroidism, adrenal dysfunction, primary ovarian dysfunction


Bone marrow


Anemia, leukopenia, pancytopenia


Skin


Pigmentation anomalies, hypertrichosis, alopecia, hair follicle anomalies


Clinical Features

Defects in the mitochondrial electron transport chain may manifest in any organ and at any age during life. They may show very variable patterns of inheritance, and they may be chronic or rapidly progressive. Table 17.2 presents an overview of possible symptoms of an electron transport chain defect. The cardinal symptoms of pyruvate dehydrogenase (PDH) deficiency include developmental delay, epilepsy, ataxia, and progressive encephalopathy.



If there are two symptoms that cannot be explained otherwise, and particularly if they belong to different organ systems, the possibility of a mitochondrial disorder should be considered.


However, mitochondrial disease can also manifest as pure myopathy. Typical constellations of clinical features have been grouped together and designated as syndromes (Table 17.3). Whereas mtDNA-coded defects causing typical syndromes are found more often in adults, mutations of nuclear genes causing variable symptoms predominate in children (Table 17.3

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Jun 4, 2016 | Posted by in NEUROLOGY | Comments Off on Metabolic Diseases

Full access? Get Clinical Tree

Get Clinical Tree app for offline access